MSH|^~\&|Reports|CML||20617|200507141540-500||ORU^R01||1|2.3PID|1|||5803549483^VR^ON|TUJONRHA^POKEU||19300126|M|||||0990009000ORC|NW|CT71691|||F|||||||193658^DXSKDS NFADNPTDI Z|||20040713OBR|1|CT71691||111F^GLUCOSE FASTING||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FOBX|1|ST|3009^GLUCOSE FASTING|CHEMISTRY^^|7.5|MMOL/L|3.3-6.1|A|||F||303^1003009||70OBR|2|CT71691||067^CREATININE||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FOBX|1|ST|3180^CREATININE|CHEMISTRY^^|70|UMOL/L|60-127||||F||303^1003180||70OBR|3|CT71691||252^URIC ACID (URATE)||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FOBX|1|ST|3200^URATE|CHEMISTRY^^|395|UMOL/L|180-450||||F||303^1003200||70OBR|4|CT71691||226^SODIUM||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FOBX|1|ST|3210^SODIUM|CHEMISTRY^^|140|MMOL/L|135-146||||F||303^1003210||70OBR|5|CT71691||204^POTASSIUM||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FOBX|1|ST|3220^POTASSIUM|CHEMISTRY^^|3.9|MMOL/L|3.5-5.2||||F||303^1003220||70OBR|6|CT71691||053^CHLORIDE||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FOBX|1|ST|3230^CHLORIDE|CHEMISTRY^^|99|MMOL/L|95-108||||F||303^1003230||70OBR|7|CT71691||222^SGOT (AST)||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FOBX|1|ST|3370^AST|CHEMISTRY^^|25|U/L|6-42||||F||303^1003370||70OBR|8|CT71691||191^PHOSPHATASE ALKALINE||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FOBX|1|ST|3360^ALK PHOS|CHEMISTRY^^|65|U/L|30-110||||F||303^1003360||70OBR|9|CT71691||030^BILRUBIN TOTAL||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FOBX|1|ST|3340^TOTAL BILIRUBIN|CHEMISTRY^^|12.0|UMOL/L|0.0-23.0||||F||303^1003340||70OBR|10|CT71691||117^HDL/LDL||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FOBX|1|ST|3120^CHOLESTEROL|CHEMISTRY^^|6.95|MMOL/L|TARGET <5.20|A|||F||365^1003120||70OBX|2|ST|3140^TRIGLYCERIDES|CHEMISTRY^^|1.16|MMOL/L|TARGET <1.71||||F||365^1003140||70OBX|3|ST|3923^HDL CHOLESTEROL|CHEMISTRY^^|1.25|MMOL/L|TARGET >1.29|A|||F||365^1003923||70NTE|1|L|NOTE:  NEW REFERENCE RANGEOBX|4|ST|3933^LDL CHOLESTEROL|CHEMISTRY^^|5.17|MMOL/L|SEE TARGETS|A|||F||365^1003933||70NTE|1|L|NOTE:  NEW REFERENCE RANGEOBX|5|ST|3939^CHOL/HDL RATIO|CHEMISTRY^^|5.56||SEE TARGETS|A|||F||365^1003939||70NTE|1|L|CLINICAL RISK STATUS AND TARGET LIPID LEVELSNTE|2|L|*********************************************NTE|3|L|   RISK   : LDL-C --TARGETS-- CHOL/HDL RATIONTE|4|L|    LOW   : <4.50     AND       <6.0NTE|5|L| MODERATE : <3.50     AND       <5.0NTE|6|L|   HIGH   : <2.50     AND       <4.0NTE|7|L| AS PER OAML GUIDELINES CLP-017OBR|11|CT71691||5050^URINALYSIS-ROUTINE||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FOBX|1|ST|5005^APPEARANCE|URINALYSIS^^ROUTINE:|CLEAR||||||F||510^1005005||70OBX|2|ST|5010^COLOUR|URINALYSIS^^ROUTINE:|YELLOW||||||F||510^1005010||70OBX|3|ST|5015^PH|URINALYSIS^^ROUTINE:|7.0||5.0-9.0||||F||510^1005015||70OBX|4|ST|5020^PROTEIN|URINALYSIS^^ROUTINE:|0.3|G/L|NEGATIVE|A|||F||510^1005020||70OBX|5|ST|5025^GLUCOSE|URINALYSIS^^ROUTINE:|NEGATIVE|MMOL/L|NEGATIVE||||F||510^1005025||70OBX|6|ST|5030^KETONE|URINALYSIS^^ROUTINE:|NEGATIVE|MMOL/L|NEGATIVE||||F||510^1005030||70OBX|7|ST|5040^BLOOD|URINALYSIS^^ROUTINE:|NEGATIVE||NEGATIVE||||F||510^1005040||70OBX|8|ST|5045^NITRITE|URINALYSIS^^ROUTINE:|NEGATIVE||NEGATIVE||||F||510^1005045||70OBX|9|ST|5046^LEUKOCYTE ESTERASE|URINALYSIS^^ROUTINE:|NEGATIVE||NEGATIVE||||F||510^1005046||70OBX|10|ST|5055^SPECIFIC GRAVITY|URINALYSIS^^ROUTINE:|1.017||||||F||510^1005055||70OBR|12|CT71691||393^COMPLETE BLOOD COUNT||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FOBX|1|ST|2010^HEMOGLOBIN|HEMATOLOGY^^|174|G/L|135-180||||F||201^1002010||70OBX|2|ST|2013^HEMATOCRIT|HEMATOLOGY^^|0.521|L/L|0.37-0.54||||F||201^1002013||70OBX|3|ST|2016^WBC COUNT|HEMATOLOGY^^|6.7|X10 9/L|4.0-11.0||||F||201^1002016||70OBX|4|ST|2019^RBC COUNT|HEMATOLOGY^^|5.51|X10 12/L|4.50-6.50||||F||201^1002019||70OBX|5|ST|2022^MCV|HEMATOLOGY^^|94.6|FL|80-97||||F||201^1002022||70OBX|6|ST|2025^MCH|HEMATOLOGY^^|31.6|PG|27.0-32.0||||F||201^1002025||70OBX|7|ST|2028^MCHC|HEMATOLOGY^^|334|G/L|320-360||||F||201^1002028||70OBX|8|ST|2029^RDW|HEMATOLOGY^^|14.9|%|11.0-14.5|A|||F||201^1002029||70OBX|9|ST|2030^PLATELET COUNT|HEMATOLOGY^^|191|X10 9/L|150-400||||F||201^1002030||70OBX|10|ST|2191^ABSOLUTE:  NEUTROS|HEMATOLOGY^^|4.1|X10 9/L|2.0-7.5||||F||201^1002191||70OBX|11|ST|2193^     (A)   LYMPH|HEMATOLOGY^^|1.9|X10 9/L|1.1-3.3||||F||201^1002193||70OBX|12|ST|2196^     (A)   MONO|HEMATOLOGY^^|0.5|X10 9/L|0.0-0.8||||F||201^1002196||70OBX|13|ST|2197^     (A)   EOS|HEMATOLOGY^^|0.2|X10 9/L|0.0-0.5||||F||201^1002197||70OBX|14|ST|2198^     (A)   BASO|HEMATOLOGY^^|0.0|X10 9/L|0.0-0.2||||F||201^1002198||70OBX|15|ST|2107^RBC MORPHOLOGY|HEMATOLOGY^^|NORMAL||||||F||203^1002107||70OBX|16|ST|2111^PLATELETS|HEMATOLOGY^^|NORMAL||||||F||203^1002111||70OBR|13|CT71691||341^SENSITIVE TSH||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FOBX|1|ST|4025^TSH|RIA^^|2.27|MU/L|0.30-4.70||||F||401^1004025||70OBR|14|CT71691||107^GAMMA GT||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FOBX|1|ST|3420^GAMMA GT|CHEMISTRY^^|26|U/L|5-50||||F||303^1003420||70OBR|15|CT71691||3670^MICROALB:CREAT-RU||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FOBX|1|ST|3534^CREATININE (RUR)|CHEMISTRY^^URINE CHEMISTRY:|7.5|MMOL/L|5.0-13.0||||F||313^1003534||70OBX|2|ST|3536^MICROALB/CREAT.|CHEMISTRY^^URINE CHEMISTRY:|20.8||< 2.0|A|||F||313^1003536||70OBR|16|CT71691||005RU^MICROALBUMIN-RANDOM||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FOBX|1|ST|3532^MICROALBUMIN (RUR)|CHEMISTRY^^URINE CHEMISTRY:|156.0|MG/L|BELOW 15|A|||F||313^1003532||70NTE|1|L|ELEVATED:     > 25 MG/LNTE|2|L|        ***NOTE***NTE|3|L|A 24 HOUR URINE COLLECTION ISNTE|4|L|RECOMMENDED IF THE RANDOM ALBUMINNTE|5|L|CONCENTRATION IS BORDERLINE OR ELEVATED.OBR|17|CT71691||093^HEMOGLOBIN A1C||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FOBX|1|ST|3767^HEMOGLOBIN A1C|CHEMISTRY^^|0.063||0.040-0.060|A|||F||303^1003767||70OBR|18|CT71691||700^DOCUMENTATION FEE||20040713|20040713|||||||||193658^DXSKDS NFADNPTDI Z|||||||||FFTS|1